Liu Liling, Jia Weibin, Zhou Yuanmeng, Zhou Hang, Liu Meng, Li Min, Zhang Xiuli, Gu Guofeng, Chen Zonggang
National Glycoengineering Research Center, and Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, and NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-based Medicine, Shandong University, Qingdao 266200, People's Republic of China.
National Glycoengineering Research Center, and Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, and NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-based Medicine, Shandong University, Qingdao 266200, People's Republic of China.
Int J Biol Macromol. 2022 May 1;206:277-287. doi: 10.1016/j.ijbiomac.2022.02.148. Epub 2022 Feb 28.
Considering the structural complexity of natural bone and the limitations of current treatment options, designing a biomimetic and functional tissue-engineered bone graft has been an urgent need for the replacement and regeneration of defected bone tissue. In light of the cell recruitment to the defect region, scaffold-guided bone tissue engineering has proven to be a viable strategy that is poised to deliver effective osseointegration and vascularization during bone remodeling. Herein, we provide an engineered bone scaffold based on aligned poly(lactic-co-glycolide) (PLGA) nanofibers incorporated with hyaluronic acid oligosaccharide-collagen mineralized microparticles (labeled oHA-Col/HAP) to guide the cell-specific orientation and osseointegration in bone healing. The aligned nanofibers were successfully prepared by a custom-made rotating mandrel with separating railings and HAs-Col/HAP mineralized microparticles were uniformly distributed in the composite scaffolds that acted as temporary templates for bone remodeling. The morphology, physicochemical properties and tensile strength of the scaffolds were characterized, the cell responses and in vivo biocompatibility and biodegradability of the scaffolds were also studied to evaluate the potential for bone tissue engineering. The experimental results illustrated that such anisotropic scaffolds loaded with oHA-Col/HAP microparticles mediated cell orderly arrangement conducive to the migration and recruitment of osseointegration-related cells and were stimulatory of cell proliferation. Those oHA-Col/HAP@PLGA scaffolds exhibited ideal biocompatibility and tissue regenerative capacity in vivo through a higher expression of vascularization-related genes. Overall, the novel engineered bone scaffold promises to serve as alternative candidates for bone tissue engineering applications.
考虑到天然骨的结构复杂性以及当前治疗方案的局限性,设计一种仿生且功能性的组织工程骨移植体对于缺损骨组织的替代和再生而言已成为迫切需求。鉴于细胞会募集至缺损区域,支架引导的骨组织工程已被证明是一种可行的策略,有望在骨重塑过程中实现有效的骨整合和血管化。在此,我们提供一种基于排列的聚(乳酸 - 乙醇酸)(PLGA)纳米纤维并结合低聚透明质酸 - 胶原矿化微粒(标记为oHA - Col/HAP)的工程化骨支架,以引导骨愈合过程中细胞的特定取向和骨整合。通过定制的带有分隔栏杆的旋转心轴成功制备了排列的纳米纤维,并且HAs - Col/HAP矿化微粒均匀分布在复合支架中,这些微粒充当骨重塑的临时模板。对支架的形态、物理化学性质和拉伸强度进行了表征,还研究了支架的细胞反应以及体内生物相容性和生物降解性,以评估其在骨组织工程中的潜力。实验结果表明,这种负载oHA - Col/HAP微粒的各向异性支架介导细胞有序排列,有利于骨整合相关细胞的迁移和募集,并刺激细胞增殖。那些oHA - Col/HAP@PLGA支架通过血管化相关基因的更高表达在体内表现出理想的生物相容性和组织再生能力。总体而言,这种新型工程化骨支架有望成为骨组织工程应用的替代候选物。